Infections | ≤ 40 y (n = 114) | 41–60 y (n = 127) | ≥ 61 y (n = 61) | Total (n = 302) | P value |
---|---|---|---|---|---|
No. (%) (95% CI) | No. (%) (95% CI) | No. (%) (95% CI) | No. (%) (95% CI) | ||
Measles, mumps, rubella | 30 (26.3%) (18.2–4.4) | 86 (67.7%) (58.8–75.7) | 61 (100%) (94.1–100) | 177 (58.6%) (52.8–64.2) | < 0.001 |
Varicella | 60 (52.6%) (43.5–61.8) | 55 (43.3%) (34.7–51.9) | 19 (31.1%) (19.5–42.8) | 134 (44.4%) (38.8–50.0) | 0.006 |
Tetanus and diphtheria | 35 (30.7%) (22.2–39.2) | 57 (44.9%) (36.2–53.5) | 29 (47.5%) (35.0–60.1) | 121 (40.1%) (34.5–45.6) | 0.016 |
Influenza | 1 (0.9%) (0.0–2.6) | 0 (0%) (0.0–0.0) | 44 (72.1%) (60.9–83.4) | 45 (14.9%) (10.9–18.9) | < 0.001 |
Pneumococcus | 19 (16.7%) (9.8–23.5) | 27 (21.3%) (14.4–28.4) | 12 (19.7%) (9.7–29.6) | 58 (19.2%) (14.8–23.6) | 0.531 |
Meningococcus C | 24 (21.1%) (13.6–28.5) | 37 (29.1%) (21.2–37.0) | 10 (16.4%) (7.1–25.7) | 71 (23.5%) (18.7–28.3) | 0.778 |
Hepatitis B | 19 (16.7%) (9.8–23.5) | 35 (27.6%) (19.8–35.3) | 15 (24.6%) (13.8–35.4) | 69 (22.8%) (18.1–27.6) | 0.134 |
Hepatitis A | 8 (7%) (2.3–11.7) | 5 (3.9%) (0.6–7.3) | 1 (1.6%) (0.0–4.8) | 14 (4.6%) (2.3–7.0) | 0.094 |